(Q38396485)

2 September 2017

1 reference

title

Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents (English)

1 reference

2 September 2017

1 reference

Lisa Giulino-Roth

1

1 reference

2 September 2017

Frank G Keller

series ordinal

2

1 reference

2 September 2017

David C Hodgson

series ordinal

3

1 reference

2 September 2017

Kara M Kelly

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

30 March 2015

1 reference

British Journal of Haematology

2 September 2017

published in

1 reference

2 September 2017

volume

169

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

647-660

1 reference

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention

2 September 2017

cites work

1 reference

How I treat nodular lymphocyte predominant Hodgkin lymphoma

21 January 2018

1 reference

Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group

21 January 2018

1 reference

Fertility in female survivors of Hodgkin's lymphoma.

21 January 2018

1 reference

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.

21 January 2018

1 reference

VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial

21 January 2018

1 reference

Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.

21 January 2018

1 reference

Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.

21 January 2018

1 reference

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial

21 January 2018

1 reference

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma

21 January 2018

1 reference

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031

21 January 2018

1 reference

The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma

21 January 2018

1 reference

Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma

21 January 2018

1 reference

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma.

21 January 2018

1 reference

What is the best treatment for children with limited-stage Hodgkin lymphoma?

21 January 2018

1 reference

B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models

21 January 2018

1 reference

Fertility preservation in adolescents and young adults with cancer

21 January 2018

1 reference

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

21 January 2018

1 reference

Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma

21 January 2018

1 reference

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study

21 January 2018

1 reference

Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma

21 January 2018

1 reference

ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma

21 January 2018

1 reference

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy

21 January 2018

1 reference

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

21 January 2018

1 reference

Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group

21 January 2018

1 reference

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

21 January 2018

1 reference

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).

21 January 2018

1 reference

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

21 January 2018

1 reference

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma

21 January 2018

1 reference

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

21 January 2018

1 reference

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group

21 January 2018

1 reference

CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.

21 January 2018

1 reference

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma

21 January 2018

1 reference

Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group

21 January 2018

1 reference

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

21 January 2018

1 reference

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

21 January 2018

1 reference

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

21 January 2018

1 reference

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study

21 January 2018

1 reference

Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin’s lymphoma – An Anglo-French collaborative report

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13372

1 reference

2 September 2017

1 reference